Microvascular Dysfunction as a Systemic Disease: A Review of the Evidence.
Microvascular Dysfunction as a Systemic Disease: A Review of the Evidence.
复制标题
DOI:
10.1016/j.amjmed.2022.04.006
复制
发表时间:
2022-09
影响因子:
5.9
通讯作者:
Keeley, Ellen C.
中科院分区:
文献类型:
--
作者:
Feuer, Daniel S.;Handberg, Eileen M.;Mehrad, Borna;Wei, Janet;Merz, C. Noel Bairey;Pepine, Carl J.;Keeley, Ellen C.
Microvascular dysfunction describes a varied set of conditions which includes vessel destruction, abnormal vasoreactivity, in situ thrombosis, and fibrosis which ultimately results in tissue damage and progressive organ failure. Microvascular dysfunction has a wide array of clinical presentations, ranging from ischemic heart disease to renal failure, stroke, blindness, pulmonary arterial hypertension, and dementia. An intriguing unifying hypothesis suggests that microvascular dysfunction of specific organs is an expression of a systemic illness that worsens with age and is accelerated by vascular risk factors. Studying relationships across a spectrum of microvascular diseases affecting the brain, retina, kidney, lung, and heart may uncover shared pathologic mechanisms that could inform novel treatment strategies. We review the evidence that supports the notion that MVD represents a global pathologic process. Our focus is on studies reporting concomitant microvascular dysfunction of the heart with that of the brain, kidney, retina, and lung.
登录
查看更多内容
影响因子:
24
作者:
Del Buono MG;Montone RA;Camilli M;Carbone S;Narula J;Lavie CJ;Niccoli G;Crea F
通讯作者:
Crea F
影响因子:
24
作者:
Cheung, Ning;Bluemke, David A.;Wong, Tien Yin
通讯作者:
Wong, Tien Yin
影响因子:
3.2
作者:
Fujii, Hideki;Takiuchi, Shin;Fukagawa, Masafumi
通讯作者:
Fukagawa, Masafumi
影响因子:
5.3
作者:
Arbel, Yaron;Sternfeld, Amir;Finkelstein, Ariel
通讯作者:
Finkelstein, Ariel
影响因子:
5.4
作者:
Ahmad A;Corban MT;Toya T;Sara JD;Lerman B;Park JY;Lerman LO;Lerman A
通讯作者:
Lerman A